Benlysta (belimumab) - GSK
hydroxychloroquine - Generic mfg.
Lupkynis (voclosporin) - Aurinia Pharma, Otsuka
Rituxan (rituximab) - Biogen, Zenyaku Holdings, Roche
methotrexate - Generic mfg.
cyclosporine - Generic mfg.
cyclophosphamide - Generic mfg.
prednisone - Generic mfg.
azathioprine - Generic mfg.
Saphnelo (anifrolumab) - AstraZeneca
EULAR recommendations for the management of systemic lupus erythematosus: 2023 update. (PubMed, Ann Rheum Dis) - Oct 13, 2023 - "The updated recommendations provide consensus guidance on the management of SLE, combining evidence and expert opinion." 
Journal • Cardiovascular • Genetic Disorders • Glomerulonephritis • Hematological Disorders • Immunology • Infectious Disease • Inflammatory Arthritis • Lupus • Lupus Nephritis • Nephrology • Osteoporosis • Psychiatry • Rheumatology • Systemic Lupus Erythematosus
http://www.ncbi.nlm.nih.gov/pubmed/37827694
 
Andrea Doria; Angela Tincani; Antonis Fanouriakis; Bernardo A Pons-Estel; Chetan B Mukhtyar; Chi Chiu Mok; Chris Wincup; Dafna D Gladman; David Jayne; Dimitrios T Boumpas; Edward M Vital; Elisabet Svenungsson; Eric F Morand; Frédéric A Houssiau; Gabriella Moroni; George Bertsias; György Nagy; Ian N Bruce; Ioannis Parodis; Jeanette Andersen; Johanna Mucke; John Boletis; José M Pego-Reigosa; Josef S Smolen; László Kovács; Laurent Arnaud; Luís Sousa Inês; Maria G Tektonidou; Marios Kouloumas; Marta Mosca; Martin Aringer; Matthias Schneider; Michelle Petri; Myrto Kostopoulou; Ricard Cervera; Richard A Furie; Ronald F van Vollenhoven; Sandra Navarra; Sang-Cheol Bae; Thomas Dörner; Yk Onno Teng; Yoshiya Tanaka
 
Oct 13, 2023
 
Prev Next